Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
about
Exome sequencing identifies compound heterozygous mutations in CYP4V2 in a pedigree with retinitis pigmentosa.Vitamin A and fish oils for retinitis pigmentosaSystematic Review of Randomized Clinical Trials on Safety and Efficacy of Pharmacological and Nonpharmacological Treatments for Retinitis PigmentosaDocosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphologyVFMA: Topographic Analysis of Sensitivity Data From Full-Field Static PerimetryLutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial [NCT00029289].Spectral-domain optical coherence tomography measures of outer segment layer progression in patients with X-linked retinitis pigmentosa.High levels of retinal docosahexaenoic acid do not protect photoreceptor degeneration in VPP transgenic mice.Clinical trial of lutein in patients with retinitis pigmentosa receiving vitamin AIn vitro expanded stem cells from the developing retina fail to generate photoreceptors but differentiate into myelinating oligodendrocytes.Power and sample size estimation for the clustered wilcoxon test.Rates of decline in regions of the visual field defined by frequency-domain optical coherence tomography in patients with RPGR-mediated X-linked retinitis pigmentosa.Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (Reticell -clinical trial)Outcome measure for the treatment of cone photoreceptor diseases: orientation to a scene with cone-only contrastCurrent understanding of usher syndrome type II.Dietary profile of patients with Stargardt's disease and Retinitis Pigmentosa: is there a role for a nutritional approach?A High-Throughput Drug Screening Strategy for Detecting Rhodopsin P23H Mutant Rescue and Degradation.Estimation of rank correlation for clustered data.ω-3 intake and visual acuity in patients with retinitis pigmentosa receiving vitamin AMultimodal Imaging of Central Retinal Disease Progression in a 2-Year Mean Follow-up of Retinitis PigmentosaFour-year placebo-controlled trial of docosahexaenoic acid in X-linked retinitis pigmentosa (DHAX trial): a randomized clinical trial.Improvement of central retinal sensitivity six months after topical isopropyl unoprostone in patients with retinitis pigmentosaThe use of canine models of inherited retinal degeneration to test novel therapeutic approaches.Clinical and Rehabilitative Management of Retinitis Pigmentosa: Up-to-Date.Cell replacement and visual restoration by retinal sheet transplantsGene therapy in animal models of autosomal dominant retinitis pigmentosaThe cell stress machinery and retinal degeneration.RPGR-associated retinopathy: clinical features, molecular genetics, animal models and therapeutic options.Variegated yet non-random rod and cone photoreceptor disease patterns in RPGR-ORF15-associated retinal degeneration.Visual loss and perimetric sensitivity in eyes with retinitis pigmentosa.Light, lipids and photoreceptor survival: live or let die?Electroretinography Reveals Difference in Cone Function between Syndromic and Nonsyndromic USH2A Patients.Current concepts in the treatment of retinitis pigmentosa.The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.Inner segment ellipsoid band length is a prognostic factor in retinitis pigmentosa associated with EYS mutations: 5-year observation of retinal structure.Docosahexaenoic Acid Slows Visual Field Progression in X-Linked Retinitis Pigmentosa: Ancillary Outcomes of the DHAX Trial.Safety assessment of docosahexaenoic acid in X-linked retinitis pigmentosa: the 4-year DHAX trial.Association of Vitamin A Supplementation With Disease Course in Children With Retinitis Pigmentosa.
P2860
Q21090932-916912C1-B4EA-49F3-9B7E-2A1C6B298F3EQ24201664-90B6C8DE-5268-48A1-86E9-2F830EC8CCACQ26784596-C2CFA91C-2E92-4B4C-B511-B16DE7A8DA61Q28388907-BA610CD7-0DA8-4A4A-9D02-67A48C846AD0Q30943482-CB63EDA5-5261-472B-9297-05BB28CAD92CQ33246037-5ACD0DBC-F225-4D40-8165-5F162D2920FFQ33954004-53850A42-28E9-4FE8-AAA2-BA453EACAA24Q34081413-9BBC270B-08DF-4950-9841-01D459771057Q34330189-0D36AE42-6057-4701-8588-E17FF9250354Q34359066-B3EE0BC2-FE4F-4A70-9A20-EDD94799B2EFQ35058980-CEF4F1C7-613B-4061-BA24-32B486E181BBQ35213949-4A6D72DF-EDB7-4FD6-B5D3-DBA1C056D3A3Q35368291-20AE580F-BBEE-4B06-8C45-69204EBE984BQ35740318-A665C572-8A70-4C97-B80D-4174A77AA759Q35830124-F6B50EE6-FBC6-4CEC-9E00-32208DF64570Q35902247-E53DBDD7-92C9-412D-91B4-6F556A080508Q36009841-D714AFBB-9E2A-4E11-BA60-66BA8EA43512Q36343583-F1957F98-3CB7-48F4-9693-66015F77F60AQ36554776-1C7AF467-BDBF-49DE-B1B9-0B43181F3903Q36584066-6D0EE8F5-41F9-4341-8C4B-B6DD7298B9D9Q36695020-83C3603B-6EAF-4EAA-87A1-DA1A6D83FFE2Q36879407-00FAABC5-B05B-493C-85CD-E63B1A779D60Q37458980-F6C2AA17-564D-4538-A1B1-CA44327981B4Q37963356-4AECB582-DBE4-485E-9A24-55575C934970Q38024553-658EDF56-AEEC-4FAA-87A5-C3C68953949BQ38053151-A6F0292D-3BC0-434D-A10D-551810FA9611Q38107689-B2C7670A-B5E0-45FA-8231-8A09B243C2CBQ38722345-DB60D4AF-ECD9-4288-B353-A3FC6A6AACD8Q38801986-FFB9E0CD-9F92-44C9-BD9A-588F78106FE7Q39361747-49C7D5D5-45E5-4786-A013-09632D883D17Q40703905-0AD61B67-92B6-4C43-83C1-0A0B65AA5E54Q41328140-56EFA335-7FBE-485E-BA39-F343E0C55939Q42105112-97B162A6-29E3-470C-83A4-A09673D04C71Q45873271-93E1EE7C-B8C4-4128-9620-1F541517DD57Q46835224-64411427-B4E5-4A10-ACEA-753737B0816BQ50283329-20FB712E-FFDC-4E06-BC74-194A448045A6Q50466117-2EAE5F68-58B9-424E-96D8-9CC2FD397D87Q53277528-DE75325D-C0E8-4EFE-BB34-1A65A814153E
P2860
Clinical trial of docosahexaenoic acid in patients with retinitis pigmentosa receiving vitamin A treatment.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@en
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@nl
type
label
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@en
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@nl
prefLabel
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@en
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@nl
P2093
P1433
P1476
Clinical trial of docosahexaen ...... receiving vitamin A treatment.
@en
P2093
Alexander R Gaudio
Bernard Rosner
Carol Weigel-DiFranco
Eliot L Berson
Ellen J Anderson
Ernst J Schaefer
Michael A Sandberg
Robert J Brockhurst
P304
P356
10.1001/ARCHOPHT.122.9.1297
P407
P577
2004-09-01T00:00:00Z